QQQ   319.43 (-2.79%)
AAPL   142.06 (-0.77%)
MSFT   232.90 (+0.25%)
FB   272.14 (-3.51%)
GOOGL   1,818.94 (-4.67%)
AMZN   3,232.58 (-2.81%)
TSLA   864.16 (-2.14%)
NVDA   516.71 (-3.85%)
BABA   260.25 (-2.13%)
CGC   37.83 (+6.50%)
GE   11.38 (+0.80%)
MU   75.09 (-5.56%)
AMD   88.84 (-6.20%)
NIO   57.15 (-5.24%)
T   29.14 (-2.05%)
F   10.79 (-3.57%)
ACB   11.20 (+4.97%)
BA   194.03 (-3.97%)
DIS   163.03 (-3.85%)
NFLX   523.28 (-6.88%)
GILD   65.48 (-1.83%)
QQQ   319.43 (-2.79%)
AAPL   142.06 (-0.77%)
MSFT   232.90 (+0.25%)
FB   272.14 (-3.51%)
GOOGL   1,818.94 (-4.67%)
AMZN   3,232.58 (-2.81%)
TSLA   864.16 (-2.14%)
NVDA   516.71 (-3.85%)
BABA   260.25 (-2.13%)
CGC   37.83 (+6.50%)
GE   11.38 (+0.80%)
MU   75.09 (-5.56%)
AMD   88.84 (-6.20%)
NIO   57.15 (-5.24%)
T   29.14 (-2.05%)
F   10.79 (-3.57%)
ACB   11.20 (+4.97%)
BA   194.03 (-3.97%)
DIS   163.03 (-3.85%)
NFLX   523.28 (-6.88%)
GILD   65.48 (-1.83%)
QQQ   319.43 (-2.79%)
AAPL   142.06 (-0.77%)
MSFT   232.90 (+0.25%)
FB   272.14 (-3.51%)
GOOGL   1,818.94 (-4.67%)
AMZN   3,232.58 (-2.81%)
TSLA   864.16 (-2.14%)
NVDA   516.71 (-3.85%)
BABA   260.25 (-2.13%)
CGC   37.83 (+6.50%)
GE   11.38 (+0.80%)
MU   75.09 (-5.56%)
AMD   88.84 (-6.20%)
NIO   57.15 (-5.24%)
T   29.14 (-2.05%)
F   10.79 (-3.57%)
ACB   11.20 (+4.97%)
BA   194.03 (-3.97%)
DIS   163.03 (-3.85%)
NFLX   523.28 (-6.88%)
GILD   65.48 (-1.83%)
QQQ   319.43 (-2.79%)
AAPL   142.06 (-0.77%)
MSFT   232.90 (+0.25%)
FB   272.14 (-3.51%)
GOOGL   1,818.94 (-4.67%)
AMZN   3,232.58 (-2.81%)
TSLA   864.16 (-2.14%)
NVDA   516.71 (-3.85%)
BABA   260.25 (-2.13%)
CGC   37.83 (+6.50%)
GE   11.38 (+0.80%)
MU   75.09 (-5.56%)
AMD   88.84 (-6.20%)
NIO   57.15 (-5.24%)
T   29.14 (-2.05%)
F   10.79 (-3.57%)
ACB   11.20 (+4.97%)
BA   194.03 (-3.97%)
DIS   163.03 (-3.85%)
NFLX   523.28 (-6.88%)
GILD   65.48 (-1.83%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 IDEXX LaboratoriesIpsenNeogenImmunomedicsQuidel
SymbolNASDAQ:IDXXOTCMKTS:IPSEYNASDAQ:NEOGNASDAQ:IMMUNASDAQ:QDEL
Price Information
Current Price$465.18$21.75$82.66$87.86$224.21
52 Week RangeBuyBuyHoldHoldHold
MarketRank™
Overall Score1.50.81.21.22.0
Analysis Score1.50.01.21.22.2
Community Score2.92.32.12.42.6
Dividend Score0.00.00.00.00.0
Ownership Score1.70.01.71.71.7
Earnings & Valuation Score1.31.91.30.63.8
Analyst Ratings
Consensus RecommendationBuyBuyHoldHoldHold
Consensus Price Target$395.67N/A$81.50$52.00$250.60
% Upside from Price Target-14.94% downsideN/A-1.40% downside-40.81% downside11.77% upside
Trade Information
Market Cap$39.68 billion$7.29 billion$4.40 billion$20.31 billion$9.43 billion
Beta0.881.190.52.90.45
Average Volume388,7338,813245,8134,013,1311,116,434
Sales & Book Value
Annual Revenue$2.41 billion$3.02 billion$418.17 million$290,000.00$534.89 million
Price / Sales16.492.4210.5270,028.6617.63
Cashflow$5.62 per share$2.49 per share$1.47 per shareN/A$4.87 per share
Price / Cash82.768.7456.15N/A46.07
Book Value$2.07 per share$5.86 per share$14.60 per share$1.38 per share$13.44 per share
Price / Book224.723.715.6663.6716.68
Profitability
Net Income$427.72 million$-56,780,000.00$59.47 million$-357,190,000.00$72.92 million
EPS$4.89$1.89$1.13($1.84)$2.73
Trailing P/E Ratio81.0411.5172.51N/A26.32
Forward P/E Ratio67.329.8962.15N/A5.93
P/E Growth4.55N/A7.00N/A0.21
Net Margins19.20%N/A13.92%N/A36.91%
Return on Equity (ROE)198.91%N/A8.13%-132.40%63.31%
Return on Assets (ROA)25.75%N/A7.45%-51.32%40.55%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio1.93%N/AN/AN/AN/A
Current Ratio1.65%1.06%12.97%12.84%2.70%
Quick Ratio1.24%0.89%10.90%12.58%2.24%
Ownership Information
Institutional Ownership Percentage85.06%N/A92.79%88.89%84.04%
Insider Ownership Percentage2.53%N/A0.90%12.00%14.10%
Miscellaneous
Employees9,2005,8001,7643661,250
Shares Outstanding85.30 million335.26 million53.24 million231.14 million42.07 million
Next Earnings Date2/2/2021 (Confirmed)2/11/2021 (Estimated)3/23/2021 (Estimated)N/A2/10/2021 (Estimated)
OptionableOptionableNot OptionableOptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.